Location: Home
  • search
  • go
  • Relate News
  • 1/6/2022CDE Issues the Technical Guidelines for Preparing the Risk Analysis an...
  • 1/6/2022CDE Issues the Technical Guidelines for Pharmacokinetic Study of Patie...
  • 1/6/2022CDE Issues the Technical Guidance for Clinical Trial Protocols of Drug...
  • 1/6/2022CDE Issues the Technical Guidance for Clinical Research of Rare Diseas...
  • 1/6/2022NMPA Solicits Comments on the Draft of GMP's Cell Therapy Product Appe...
  • 1/6/2022JPO Announces Initial Year Procurement Volumes and Implementation Time...
  • 1/5/2022Junshi Biosciences Terminates Promotion Agreement with Astrazeneca
  • 1/5/20223SBio's Sunshine Guojian and Syncromune Enter Co-development Deal for ...
  • 1/5/2022CDE Issues the Technical Guidance for Food Impacts in New Drug R&D Pro...
  • 1/5/2022CDE Issues the Guidelines for Clinical Studies of Crohn's Disease Drug...
  • 1/5/2022CDE Issues the Technical Guidelines for Clinical Trials of Ulcerative ...
  • 1/5/2022CDE Issues the Guidance Principles for Clinical Trials of Direct Antiv...
  • 1/5/2022Review of Sino-Foreign Drug Out-licensing Deals in 2021
  • 1/5/2022Review of Chinese Pharma In-licensing Deals in 2021
  • 1/5/2022SMEI: Chinese Urban Chemical Drug Hospital Market Rebounded 10% in 3Qs...
  • 1/5/2022China 2021: The NRDL Readout (PharmExec)
  • 1/4/2022CDE Issues on the Technical Guidelines for Writing Safety Reference In...
  • 1/4/2022NMPA Announces OTC Switch of Four Rx Drug Products
  • 1/4/2022Santhera Enters into Exclusive License Agreement with Sperogenix for V...
  • 1/3/2022Daewoong Submits BTX Product Nabota in China
  • 1/3/2022Hanmi Pharma Out-licenses Retinal Disease Drug to China's AffaMed
  • 1/3/2022Third Former GSK Scientist Pleads Guilty to Stealing Trade Secrets to ...
  • 12/31/2021CDE Issues Clarification for Implementation of ICH M9
  • 12/31/2021Long Winter Sets In for Both MNCs and Domestic Champions as 2021 NRDL ...
  • 12/30/2021Sirnaomics Launches IPO on the Main Board of Stock Exchange of Hong K...
  • 12/30/2021Ark Biopharma Enters Into License Deal with Commave for ADHD Drug Azst...
  • 12/30/2021Ant Group to Shut Down China's Largest Crowdfunded Healthcare Mutual ...
  • 12/30/2021NMPA and Chinese Customs Announce Addition of Zhongshan City's Zhongsh...
  • 12/30/2021CDE Issues the Guiding Principles for Comprehensive Efficacy Analysis ...
  • 12/30/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (54...
  • Page:98/719 Total number of articles:21546: [First][<<] [96] [97] [98] [99] [100] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group